Description
ZOLADEX LA Depot 10.8mg – Single Dose
ZOLADEX LA (Long-Acting) Depot 10.8mg contains Goserelin acetate, a gonadotropin-releasing hormone (GnRH) analogue used in the management of hormone-sensitive conditions. It is administered as a subcutaneous implant every 12 weeks for long-term hormonal therapy.
ZOLADEX LA 10.8mg is primarily indicated for the treatment of prostate cancer, endometriosis, breast cancer (in premenopausal women), and for endometrial thinning prior to surgery. By suppressing the pituitary-gonadal axis, it significantly reduces estrogen or testosterone production, helping to control hormone-dependent disease progression.
Key Features:
-
Contains Goserelin acetate equivalent to 10.8 mg of Goserelin
-
Long-acting 12-week depot formulation
-
Used in prostate cancer, endometriosis, and hormone-sensitive breast cancer
-
Administered subcutaneously by a healthcare professional
-
Single-use sterile prefilled syringe
Usage:
To be administered under the supervision of a qualified healthcare provider. Intended for subcutaneous injection in the anterior abdominal wall.
Note: Not for use in pregnancy. Periodic monitoring of hormone levels and clinical response is recommended.
Reviews
There are no reviews yet.